CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $76,000 | +123.5% | 22,680 | +100.0% | 0.01% | 0.0% |
Q3 2020 | $34,000 | -34.6% | 11,340 | 0.0% | 0.01% | -43.8% |
Q2 2020 | $52,000 | +18.2% | 11,340 | 0.0% | 0.02% | -5.9% |
Q1 2020 | $44,000 | +2.3% | 11,340 | 0.0% | 0.02% | +6.2% |
Q4 2019 | $43,000 | -28.3% | 11,340 | 0.0% | 0.02% | -33.3% |
Q3 2019 | $60,000 | +17.6% | 11,340 | -14.7% | 0.02% | +14.3% |
Q2 2019 | $51,000 | -19.0% | 13,300 | +8.1% | 0.02% | -22.2% |
Q1 2019 | $63,000 | +162.5% | 12,300 | 0.0% | 0.03% | +107.7% |
Q4 2018 | $24,000 | – | 12,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |